Interestingly, the interplay between LRRK2 and GCase was also identified in iPSC-derived astrocytes derived from PD patients carrying GBA1 mutations, in which LRRK2 inhibition could rescue the lysosomal and inflammatory defects18. This evidence concerns the gene GBA1 and Parkinson disease.